Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SVB Leerink Maintains Outperform on Insmed, Lowers Price Target to $50

SVB Leerink Maintains Outperform on Insmed, Lowers Price Target to $50

SVB Leerink analyst Joseph Schwartz maintains Insmed (NASDAQ:INSM) with a Outperform and lowers the price target from $52 to $50.

byBenzinga Newsdesk

October 27, 2022

1 minute read

SVB Leerink analyst Joseph Schwartz maintains Insmed (NASDAQ:INSM) with a Outperform and lowers the price target from $52 to $50.

SEC’s Gensler Roars: ‘We Have The Dollar, No More Crypto Needed’

By Murtuza Merchant

June 6, 3:44 PM

Securities and Exchange Commission (SEC) Chair Gary Gensler said the U.S.

$BNB

Analyst Ratings

The Analyst Verdict: Atmus Filtration Techs In The Eyes Of 4 Experts

By Benzinga Insights

April 15, 9:00 AM

4 analysts have expressed a variety of opinions on Atmus Filtration Techs (NYSE:ATMU) over the past quarter, offering…

ATMU

Planet Fitness ‘An Illegal Billing Operation With Gyms On The Side’: Short Seller

By Chris Katje

January 19, 12:20 PM

A leading gym operator in the United States is the target of a new short report. The Thursday report from Bear Cave lays out a case that Planet Fitness has issues with overbilling, uncancellable memberships and is lying about the locations of its gyms.

PLNT